Ozempic face is caused by rapid volume loss in both the superficial and deep fat pads of the face, as well as changes in skin barrier function, Moschitto continues, The superficial fat pads provide direct structural support to the skin
The FDA's goal timeline is 10 months for standard review, but complex peptides often take 18-24 months
What is accelerating GLP-1 Adherence Platforms Market adoption, and what is holding it back
Used syringes should be disposed of in a sharps container right away
Using non-standard weight-loss drugs that promise quick results can have severe negative effects on the body, even leading to fatal consequences
The researchers says this body of evidence increases the need to study GLP-1 drugs as a potential approach to addressing persistent obesity in the US, which currently affects about 42 percent of the U.S